A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07322367
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 77 Years
Healthy Volunteers
Not accepted

Interventions

  • Portal Message with Reminder Text Messages — OTHER
    If the participant has an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial portal message, a final reminder text message a day before their scheduled appointment, and potentially an 'in progress' text message reminder if they start the mPATH-Lung program but do not complete it. If the participant does not have an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial portal message, the final reminder message 8 days after the initial message, and potentially an 'in progress' text message reminder.
  • Text Message with Reminder Text Messages — OTHER
    If the participant has an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial message, a final reminder text message a day before their scheduled appointment, and potentially an 'in progress' text message reminder. If the participant does not have an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial message, the final reminder message 8 days after the initial message, and potentially an 'in progress' text message reminder.
  • Portal message only — OTHER
    Participant will only receive portal message with no reminder text messages.
  • Usual Care — OTHER
    Standard of care

Study Details

To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.

Key Dates

Start date
Mar 25, 2026
Status verified
Mar 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
27,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Experimental: Arm A
    Patient portal message first followed by up to 3 reminder text messages.
  • Experimental: Arm B
    Text message only with up to 3 reminder text messages.
  • Experimental: Arm C
    Portal message only with no reminder messages.
  • Active Comparator: Usual Care Arm
    Patients receive usual care.

Primary Outcome Measure

Number of Participants to Complete Lung Screening CT - Primary Effectiveness [ Time Frame: 90 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Atrium Health Wake Forest BaptistWinston-SalemNorth Carolina27157
Study Coordinator, MD
[email protected]
704-355-2000
Study Coordinator
Brent Heideman, Jr., MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Winston-Salem, NC

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Atrium Health Wake Forest Baptist· Winston-Salem, NC

Related Studies